Zoetis Inc.ZTS

Where ZTS's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$76.17-1.08 (-1.40%)Previous close
NYSEHealthcare

ZTS Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
ZTS Net Debt / EBITDA historyZTS Net Debt / EBITDA from Sep 2023 to Jun 2026: low 1.23, high 2, latest 2.1.171.391.621.842.07Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 1.33

ZTS Net Debt / EBITDA by year

Yearly range of ZTS’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 1.0 to 2.8, averaging 1.7.

ZTS Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.81.92.02.0
20251.31.41.81.8
20241.21.31.41.2
20231.31.41.41.3
20221.11.31.31.3
20211.01.21.31.0
20201.41.61.81.4
20191.92.12.21.9
20181.61.92.42.2
20171.72.22.41.7
20162.42.62.82.4

Get notified when ZTS Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.